FOLFOX-HAIC combined with targeted immunotherapy for initially unresectable hepatocellular carcinoma: a real-world study

福克斯 肝细胞癌 医学 免疫疗法 内科学 肿瘤科 胃肠病学 奥沙利铂 癌症 结直肠癌
作者
Yan-Cen Lu,Yu-Chen Yang,Di Ma,Junqing Wang,Fengjie Hao,Xuxiao Chen,Yongjun Chen
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:15: 1471017-1471017 被引量:20
标识
DOI:10.3389/fimmu.2024.1471017
摘要

Background: Hepatic arterial infusion chemotherapy (HAIC) with the FOLFOX regimen has demonstrated efficacy in patients with unresectable hepatocellular carcinoma (HCC). The combined targeted and immunotherapy has emerged as a first-line treatment for liver cancer. In this study, we investigated the clinical efficacy and safety of FOLFOX-HAIC in combination with targeted immunotherapy in patients with untreated, unresectable HCC. Materials and methods: Data were collected from patients with initially unresectable HCC treated at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, from June 2022 to June 2023. Tumor response and survival outcomes were assessed following the FOLFOX-HAIC combined with targeted immunotherapy, The safety was also evaluated through the incidence of related adverse events. Results: A total of 51 eligible patients were recruited. The objective response rate (ORR) based on mRECIST and RECIST 1.1 criteria were 60.8% and 45.1%, respectively. The surgical conversion rate was 25.5%. The median progression-free survival (PFS) was 15.2 months. The 1-year overall survival rate was 88.2%. Adverse events were observed in 98% patients, with 23.5% experiencing grade 3 or 4 adverse events. Conclusion: The FOLFOX-HAIC combined with targeted immunotherapy regimen is effective in patients with unresectable HCC, demonstrated by a high surgical conversion rate and manageable adverse effects. This regimen represents a potential novel first-line treatment option for HCC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
luxiaoyu发布了新的文献求助10
1秒前
kiwi发布了新的文献求助10
2秒前
倚栏听风完成签到 ,获得积分10
2秒前
3秒前
Ballas完成签到,获得积分10
3秒前
4秒前
4秒前
Seorina的应助被李一中采纳,获得10
5秒前
斯文败类的应助被荀万声采纳,获得10
5秒前
Wiki完成签到,获得积分10
5秒前
hu发布了新的文献求助10
5秒前
luoluoluoaaa123完成签到,获得积分10
7秒前
Horizon完成签到,获得积分10
7秒前
Qian发布了新的文献求助10
7秒前
xz发布了新的文献求助10
7秒前
溧谦发布了新的文献求助10
9秒前
赘婿的应助被kiwi采纳,获得10
10秒前
嘟嘟完成签到,获得积分10
11秒前
12秒前
草莓完成签到 ,获得积分10
12秒前
12秒前
liyuanyuan发布了新的文献求助10
12秒前
12秒前
13秒前
完美世界的应助被luxiaoyu采纳,获得10
13秒前
长安望星河完成签到,获得积分10
14秒前
慕青的应助被无私的画笔采纳,获得10
14秒前
顺心觅风完成签到,获得积分20
14秒前
luoluoluoaaa123关注了科研通微信公众号
14秒前
15秒前
多喝水发布了新的文献求助20
15秒前
17秒前
18秒前
葳蕤2完成签到 ,获得积分10
18秒前
19秒前
外向凡松完成签到,获得积分10
19秒前
19秒前
天天向上的应助被liyuanyuan采纳,获得10
20秒前
水弘的应助被张三说刑法采纳,获得30
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183601
求助须知:如何正确求助?哪些是违规求助? 9572875
关于积分的说明 21827816
捐赠科研通 7780716
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558197
邀请新用户注册赠送积分活动 2480485